Literature DB >> 2410583

Increased serum beta2-microglobulin levels in active celiac disease.

A Blanco, M Alonso, M L Cilleruelo, P Solis, C Calvo, E Sanchez Villares.   

Abstract

Sixty-eight sera from 36 children with celiac disease (CD) were collected in a 4-year study, and the levels of beta2-microglobulin (beta2M), orosomucoid, alpha1-antitrypsin, and C-reactive protein (CRP) were measured. A simultaneous intestinal biopsy was taken in all the patients and used to classify them. The values of beta2M were 1.94 +/- 0.49 mg/L in group A (inactive CD with normal intestinal biopsy) and 2.58 +/- 0.76 mg/L in group B (active CD with flat mucosa). These levels were higher than in the normal controls (1.87 +/- 0.49 mg/L, p less than 0.005) and in the other 19 patients with chronic diarrhea of another cause (1.72 +/- 0.63 mg/L, p less than 0.005). CRP values were generally normal; orosomucoid and alpha1-antitrypsin were variable and they did not correlate with beta2M levels. Beta2M was increased at the time of diagnosis in seven of eight (87.5%) of the CD children and only in three of 19 (15.7%) of nonceliac patients with chronic diarrhea of another cause (p less than 0.005). In 12 children with CD, serial studies were possible. The highest beta2M level coincided with a flat mucosa in 10 cases. The increase of beta2M could be related to the intestinal infiltration or even to the lymphocyte activation. It may also be a useful noninvasive method for evaluating the activity of CD.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2410583     DOI: 10.1097/00005176-198506000-00011

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  2 in total

1.  Estimation of serum beta-2-microglobulin in children with malabsorption disorders syndrome.

Authors:  A Kochańska-Dziurowicz; C Bukowska
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

2.  Signs of increased leakage over the jejunal mucosa during gliadin challenge of patients with coeliac disease.

Authors:  B Lavö; L Knutson; L Lööf; B Odlind; R Hällgren
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.